hero image
J. Aaron Johnson, PhD - Augusta University. Augusta, GA, US

J. Aaron Johnson, PhD J. Aaron Johnson, PhD

Director of the Institute of Public and Preventive Health and Professor of Psychology | Augusta University

Augusta, GA, UNITED STATES

For two decades, J. Aaron Johnson's research has focused on evidence-based practices, primarily in substance use prevention.

Social

Biography

J. Aaron Johnson, PhD is Director of the Institute of Public and Preventive Health and Professor of Psychology at Augusta University. He received his doctorate from the University of Georgia. For two decades, his research has focused on the adoption and implementation of evidence-based practices, primarily in substance use prevention and SUD treatment. His work has been widely published in journals across many disciplines including public health, nursing, medicine, addiction, psychology, and sociology.

Areas of Expertise (4)

Alcohol Screening

Brief Interventions

Treatment of Substance Use Disorders

Opioid Epidemic

Accomplishments (5)

Education/Teaching Pedagogy Poster Award – International Society of Psychiatric Nurses Annual Conference

2017

Frank Bradway Rogers Information Advancement Award – Medical Library Association

2020

Invited Plenary – Carolina Undergraduate Social Science Symposium

2016

Fellow – 13th Annual OBSSR/NHLBI Summer Institute on Design and Conduct of Randomized Clinical Trials

2013

Best Poster – Georgia Association of Family Physicians Research Poster

2012

Education (3)

University of Georgia: PhD, Sociology 2000

University of Georgia: MA, Sociology 1995

Presbyterian College: BS, Sociology and Political Science 1993

Media Appearances (5)

What’s happening at Augusta University? Sept. 19-25

JAGWire  online

2022-09-19

After nearly two decades of rising overdose deaths, the opioid crisis was finally declared a public health emergency in 2017. In the last decade, Dr. Aaron Johnson, director of the Institute of Public and Preventive Health at Augusta University, has been working with physicians and community-based organizations in Georgia to implement programs to help those who may be addicted to opioids. “I tell a lot of people that Georgia has really been lucky. If you look at overdose rates and other issues around the country, given our size, I feel we’ve been fortunate,” said Johnson.

view more

Georgia battles opioid crisis with community programs, education

JAGWire  online

2022-09-13

Dr. Aaron Johnson, director of the Institute of Public and Preventive Health at Augusta University, said during the last three decades, we’ve seen three phases of the epidemic. “Initial issues were prescription opioids,” said Johnson. “A lot of state and federal policy changes, like prescription drug monitoring programs, made prescription opioids more difficult to obtain. So the epidemic sort of shifted from prescription opioids to heroin. We started to get a handle on it a bit and then we started to see the fentanyl epidemic. Fentanyl is a synthetic opioid that is 100 times more potent than morphine.”

view more

Healthy Georgia report gives snapshot of state compared to rest of US

JAGWire  online

2022-05-25

Dr. Aaron Johnson, director of IPPH, said one surprise in the study was finding that the obesity level is still on the rise — not only in Georgia, but also throughout the U.S. “As much time, effort and expense that we put into addressing the obesity epidemic over the last 20-plus years, it is still steadily going up,” Johnson said.

view more

Georgia battles opioid crisis with community programs, education

Jagwire  online

2022-09-13

Opioid overdose-related deaths in the United States began to rise in the late 1990s after decades of mostly heroin-related overdoses in primarily urban areas. Much of the increases in opioid-related death in the early 2000s can be attributed to the rise of prescription opioids driven by aggressive marketing campaigns of pharmaceutical companies who convinced the Food and Drug Administration, providers and patients that these new opioid pain relievers were non-addictive. After nearly two decades of rising overdose deaths, the opioid crisis was finally declared a public health emergency in 2017. Dr. Aaron Johnson, director of the Institute of Public and Preventive Health at Augusta University, said during the last three decades, we’ve seen three phases of the epidemic.

view more

Fentanyl deaths outnumber traffic deaths in Richmond and Aiken Counties

WJBF  tv

2022-10-25

There is an alarming number of people dying from a specific type of opioid. These types of deaths even outnumber traffic fatalities. “You never know whether this pill here is going to be your last one,” said Mark Bowen, Richmond County Coroner. It’s the unexpected drug killing people now. Opioid death by fentanyl. “Fentanyl related overdose deaths have become increasingly prominent,” said Aaron Johnson, Augusta University’s Director of Institute of Public and Preventive Health. “So, the most recent numbers I saw indicated that about 75-80 percent of overdose deaths are now fentanyl related. Five years ago that would have been 15-20 percent.”

view more

Articles (3)

Using Actigraphy as a measure of cortical arousals in Cardiopulmonary Sleep Studies

Sleep Medicine

2022 Results: A repeated measures ANOVA will be used in order to determine the differences between AHI for participants between conditions and a correlation between cortical arousals (EEG) and movement (actigraphy) after obstructive hypopnoeic episodes will be calculated. Conclusions: This study assesses the risk of underdiagnosing OSA in ambulatory cardiovascular studies that are already used within practice.

view more

Study protocol: The maternal health multilevel intervention for racial equity (maternal health MIRACLE) project

Contemporary Clinical Trials

2022 Purpose To test the effectiveness and cost-effectiveness of a multilevel intervention for population-level African American (AA) severe maternal morbidity and mortality. Background Severe maternal morbidity and mortality in the U.S. disproportionately affect AA women. Inequities occur at many levels, including community, provider, and health system levels. Design

view more

Racial and Ethnic Inequities in Financial Hardship Among CVD Patients in the USA During the Pre-and Post-Affordable Care Act Era

Journal of Racial and Ethnic Health Disparities

2022 The Affordable Care Act (ACA) has substantially expanded access to health insurance coverage, resulting in a reduction in financial hardship, defined as ability to pay medical bills, among cardiovascular disease (CVD) patients in the post-ACA era. However, it is not known whether implementation of the ACA improved the racial and ethnic inequity in financial hardship among CVD patients. As such, using data from the 2011 to 2018 waves of the National Health Interview Survey (NHIS), this paper aims to assess the odds of facing financial hardship among non-Hispanic-White,-Black,-Asian, and Hispanic CVD patients, before and after the implementation of the ACA.

view more